We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

FTC Says Patent Infringement Suits Are Not Antitrust Proof

Law360 (June 7, 2018, 7:01 PM EDT) -- Takeda Pharmaceutical Co. Ltd. can't dodge antitrust counterclaims from generic drugmaker Zydus Pharmaceuticals (USA) Inc. simply by arguing that it is allowed to sue generics companies for patent infringement when they...
To view the full article, register now.